{
  "pmid": "21309780",
  "uid": "21309780",
  "title": "Time to rethink clinically important outcomes in platelet transfusion trials.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Heddle",
      "fore_name": "Nancy M",
      "initials": "NM",
      "name": "Nancy M Heddle",
      "affiliations": [
        "Department of Medicine, McMaster University, Hamilton, Ontario, Canada. heddlen@mcmaster.ca"
      ]
    },
    {
      "last_name": "Arnold",
      "fore_name": "Donald M",
      "initials": "DM",
      "name": "Donald M Arnold",
      "affiliations": []
    },
    {
      "last_name": "Webert",
      "fore_name": "Kathryn E",
      "initials": "KE",
      "name": "Kathryn E Webert",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "Transfusion",
    "iso_abbreviation": "Transfusion",
    "issn": "1537-2995",
    "issn_type": "Electronic",
    "volume": "51",
    "issue": "2",
    "pub_year": "2011",
    "pub_month": "Feb"
  },
  "start_page": "430",
  "end_page": "434",
  "pages": "430-4",
  "language": "eng",
  "publication_types": [
    "Journal Article"
  ],
  "keywords": [
    "Biomarkers",
    "Clinical Trials as Topic",
    "Hemorrhage",
    "Humans",
    "Platelet Transfusion",
    "Randomized Controlled Trials as Topic",
    "Research Design",
    "Severity of Illness Index",
    "Treatment Outcome",
    "World Health Organization"
  ],
  "article_ids": {
    "pubmed": "21309780",
    "doi": "10.1111/j.1537-2995.2010.02982.x"
  },
  "doi": "10.1111/j.1537-2995.2010.02982.x",
  "dates": {
    "completed": "2011-04-04",
    "revised": "2015-11-19"
  },
  "chemicals": [
    "Biomarkers"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T14:04:53.287678",
    "pmid": "21309780"
  }
}